Clinical Trials Logo

Filter by:
NCT ID: NCT00302796 Completed - Back Pain Clinical Trials

Antibiotic Treatment to Patients With Low Back Pain

Start date: March 2006
Phase: Phase 4
Study type: Interventional

A large proportion of patients with Low Back Pain (LBP) (80 %) are classified as "non-specific", due to the lack of a patho-anatomical diagnosis. This term is not satisfactory, since it implies uncertainty for both the patient and the clinician. Modic changes have recently been identified as a pain giving patho-anatomical diagnosis for a considerable percentage (20-30 %) of LBP patients. The causes of these Modic changes have not been determined conclusively but bacterial infection is among the plausible causes for those following a disc herniation. Purpose The aim of this study is to assess the clinical effect of antibiotic treatment compared to placebo, in patients with LBP and Modic changes following a lumbar herniated disc. Design A double blind prospective clinically controlled trial. Patients will be randomized by a blinded observer to either Group A: 1 antibiotic tablet 45 patients Group B: 1 placebo tablet 36 patients Group C: 2 antibiotic tablets 45 patients Group D: 2 placebo tablets 36 patients The patients will take the drug three times a day for 100 days.

NCT ID: NCT00302328 Completed - Clinical trials for Idiopathic Macular Hole

Trial of Prognostic Factors and Surgical Methods for the Treatment of Idiopathic Macular Holes

Start date: August 2005
Phase: N/A
Study type: Interventional

The project is a randomized clinical trial with a follow up time of 12 months comparing the effects of surgical treatment of idiopathic macular holes. Patients are randomized to vitrectomy alone, vitrectomy plus indocyanine green (ICG) assisted inner limiting membrane ( ILM) peeling or vitrectomy plus trypan blue (tb) assisted ILM peeling. At baseline patients are characterized using early treatment diabetic retinopathy study (ETDRS) visual charts, tests of aniseikonia, optical coherence tomography 3 (OCT3), visual field and fundus photography. Per- and postoperative complications are registered. Data analyses will help clarify the effect of ILM peeling on hole closure and visual acuity. Comparing results after ICG- and tb assisted ILM peeling will help clarify the topic of a toxic effect on retinal cells after staining and peeling of the ILM. Changes in intraretinal morphology before and after dye-assisted ILM peeling will be studied using OCT3 imaging and the patients' subjective opinion on the surgical results will be analyzed using quality of life questionnaires and metamorphopsia tests.

NCT ID: NCT00302302 Completed - Blood Glucose Clinical Trials

The Effects of L-arabinose on Intestinal Sucrase Activity in Man

Start date: September 2005
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate the effect of L-arabinose in a sugar-rich meal on intestinal sucrase activity in healthy volunteers by measuring postprandial blood glucose and insulin, and selected intestinal hormonal responses to increasing doses of L-arabinose.

NCT ID: NCT00302289 Completed - Obesity Clinical Trials

B181: Stimulation of Thermogenesis by Bio-Active Food Ingredients

Start date: January 2000
Phase: Phase 1
Study type: Interventional

The primary aim was to measure the effect of green tea extract, tyrosine and caffeine on energy expenditure, appetite ratings and spontaneous energy intake together with recording of side effects in healthy normal weight subjects.

NCT ID: NCT00302276 Completed - Obesity Clinical Trials

Weight Loss Maintenance of a New Bioactive Compound (Metobes-Long)

Start date: January 2004
Phase: Phase 2/Phase 3
Study type: Interventional

The objective of the present study was to investigate the acute and sub-chronic effect of a supplement containing green tea extract, capsaisin, caffeine, tyrosine and calcium or placebo taken t.i.d on thermogenesis, body fat loss, and fecal fat excretion. Furthermore, if a 8-week supplementation could prevent weight-regain after initial 4-week weight loss.

NCT ID: NCT00302263 Completed - Obesity Clinical Trials

B181 Metobes-III: Weight Loss Maintenance of a New Bioactive Compound (Metobes-Long)

Start date: January 2005
Phase: Phase 2/Phase 3
Study type: Interventional

To investigate the 5-hour acute effect on energy expenditure, substrate oxidation and ad libitum food intake after intake of the Metobes-compound (green tea extract, capsaicin, tyrosine, caffeine). Furthermore, to investigate if the effect of the Metobes-compound can be inhibited by blocking the β-adrenergic receptors. The effect of the Metobes-compound will be investigated by: 1. 5-hour energy expenditure and respiratory quotient (ventilated hood). 2. 5-h change in blood pressure and heart rate 3. 5-h change in sympathetic/parasympathetic ratio. 4. Ad libitum energy intake. 5. Self-reported postprandiel appetite sensations (VAS).

NCT ID: NCT00302094 Completed - Anal Cancer Clinical Trials

Image Fusion PET, CT and 3D-ultrasound Examinations

Start date: June 2006
Phase: N/A
Study type: Observational

CT-examinations are used in computer programs which are used in the planning of external radiation of cancers in the anal canal. In CT the structures of the anal canal are hardly visible. 3D-ultrasound examinations offer a better visualisation of normal and pathological structures of the anal canal. The description of the tumour made from the 3D-ultrasound examination is used in the planning of the external radiation. PET-CT is used to visualise tumour activity also in lymp nodes. The hypothesis of the study is that image fusion of PET, CT and 3D-ultrasound will offer better visualisation of tumour and hereby more accurate diagnostics and treatment.

NCT ID: NCT00300547 Completed - Clinical trials for Obstructing Colorectal Cancer

Preoperative Assessment for Synchronous Carcinoma or Polyps With Magnetic Resonance (MR) Colonography

Start date: March 2007
Phase: Phase 4
Study type: Interventional

The purpose of this study is to diagnose possible synchronous carcinomas and polyps with magnetic resonance (MR) colonography in patients booked for operation because of carcinoma in the descending or sigmoid colon, where a preoperative full colonoscopy is not possible. Two days before colonography, patients ingest a 200 ml Barium sulfate solution four times a day, which will render fecal masses "invisible" on the following MR colonography. The study is primarily a feasibility study with altered operative strategy as a secondary end-point. Gold standard is colonoscopy and operation.

NCT ID: NCT00300131 Completed - Clinical trials for Coronary Artery Disease

ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation

ABSORB A
Start date: March 2006
Phase: Phase 3
Study type: Observational

Prospective, open-labeled First in Man Clinical Investigation enrolling patients with visually estimated nominal vessel diameter of 3.0 mm receiving a single 3.0 x 12 mm or 3.0 x 18 mm BVS EECSS containing 98 microgramme per cm² of surface area.

NCT ID: NCT00300066 Completed - Kidney Disease Clinical Trials

Assessment of Serum Cystatin C as a Marker of Kidney Function in Children

Start date: March 2006
Phase: Phase 2
Study type: Observational

The purpose of this study is to assess serum cystatin C as a marker of kidney function (glomerular filtration rate, GFR) in children aged 2-14. The individual production rate and possible extra renal elimination of cystatin C based on body composition data is included to develop new algorithms to estimate GFR. Furthermore, day-to-day variation on serum cystatin C is investigated.